Shares of Indian pharmaceutical companies, including Aurobindo Pharma, Laurus Labs, IPCA Laboratories, and Lupin, dropped as much as 7% on Friday after U.S. President Donald Trump signaled that tariffs on the sector were imminent. Speaking to reporters aboard Air Force One, Trump stated that his administration was evaluating potential tariffs on pharmaceuticals. βPharma is goingβ¦
READ MORE